Clinical complications of Mycoplasma pneumoniae disease--central nervous system.
The mechanism of the neurologic complications associated with primary atypical pneumonia is unknown. To examine the ability of Mycoplasma pneumoniae to enter the brain of experimental animals, the organism was inoculated into adult and suckling mice by various routes. After intranasal infection, M. pneumoniae was isolated from brains and lungs of both groups of mice. After intracerebral inoculation, the high levels of the mycoplasma persisted for two months or more in the brains of suckling mice. In addition, after intravenous infection, the systemic spread of infection occurred in the mice treated with high doses of cyclophosphamide. Our results suggest that M. pneumoniae may be able to reach the brain via blood and it may occur with relative ease in compromised hosts.
D000336:Aerosols; D000818:Animals; D001812:Blood-Brain Barrier / Q000187:drug effects; D001921:Brain / Q000382:microbiology; D001927:Brain Diseases / Q000209:etiology* / Q000382:microbiology; D003520:Cyclophosphamide / Q000494:pharmacology; D004198:Disease Susceptibility; D005260:Female; D007108:Immune Tolerance; D008168:Lung / Q000382:microbiology; D008297:Male; D051379:Mice; D008813:Mice, Inbred ICR; D009177:Mycoplasma pneumoniae / Q000302:isolation & purification; D011019:Pneumonia, Mycoplasma / Q000150:complications* / Q000382:microbiology; D018805:Sepsis / Q000382:microbiology
D000336:Aerosols; D003520:Cyclophosphamide